首页> 外文期刊>G3: Genes, Genomes, Genetics >mCAL: A New Approach for Versatile Multiplex Action of Cas9 Using One sgRNA and Loci Flanked by a Programmed Target Sequence
【24h】

mCAL: A New Approach for Versatile Multiplex Action of Cas9 Using One sgRNA and Loci Flanked by a Programmed Target Sequence

机译:mCAL:使用一个sgRNA和位于编程靶序列侧翼的基因座,Cas9的多功能多重作用的新方法

获取原文
       

摘要

Genome editing exploiting CRISPR/Cas9 has been adopted widely in academia and in the biotechnology industry to manipulate DNA sequences in diverse organisms. Molecular engineering of Cas9 itself and its guide RNA, and the strategies for using them, have increased efficiency, optimized specificity, reduced inappropriate off-target effects, and introduced modifications for performing other functions (transcriptional regulation, high-resolution imaging, protein recruitment, and high-throughput screening). Moreover, Cas9 has the ability to multiplex, i.e. , to act at different genomic targets within the same nucleus. Currently, however, introducing concurrent changes at multiple loci involves: (i) identification of appropriate genomic sites, especially the availability of suitable PAM sequences; (ii) the design, construction, and expression of multiple sgRNA directed against those sites; (iii) potential difficulties in altering essential genes; and (iv) lingering concerns about “off-target” effects. We have devised a new approach that circumvents these drawbacks, as we demonstrate here using the yeast Saccharomyces cerevisiae . First, any gene(s) of interest are flanked upstream and downstream with a single unique target sequence that does not normally exist in the genome. Thereafter, expression of one sgRNA and cotransformation with appropriate PCR fragments permits concomitant Cas9-mediated alteration of multiple genes (both essential and nonessential). The system we developed also allows for maintenance of the integrated, inducible Cas9-expression cassette or its simultaneous scarless excision. Our scheme—dubbed mCAL for “ M ultiplexing of C as9 at A rtificial L oci”—can be applied to any organism in which the CRISPR/Cas9 methodology is currently being utilized. In principle, it can be applied to install synthetic sequences into the genome, to generate genomic libraries, and to program strains or cell lines so that they can be conveniently (and repeatedly) manipulated at multiple loci with extremely high efficiency.
机译:利用CRISPR / Cas9进行基因组编辑已在学术界和生物技术行业广泛采用,以操纵各种生物体中的DNA序列。 Cas9本身及其指导RNA的分子工程以及使用它们的策略,提高了效率,优化了特异性,减少了不适当的脱靶效应,并引入了用于执行其他功能的修饰(转录调控,高分辨率成像,蛋白质募集,和高通量筛选)。而且,Cas9具有多路复用的能力,即作用于同一核内的不同基因组靶标。然而,当前,在多个基因座处引入并发改变涉及:(i)鉴定合适的基因组位点,尤其是合适的PAM序列的可用性; (ii)针对这些位点的多个sgRNA的设计,构建和表达; (iii)改变必需基因的潜在困难; (iv)对“脱靶”效应的担忧持续存在。我们已经设计出一种新方法来克服这些缺点,正如我们在这里使用酿酒酵母所展示的那样。首先,任何感兴趣的基因都在上游和下游侧接一个基因组中通常不存在的单一独特靶序列。此后,一种sgRNA的表达以及与适当PCR片段的共转化使Cas9介导的多个基因(必需基因和非必需基因)同时发生改变。我们开发的系统还允许维护集成的可诱导Cas9表达盒或其同时进行的无疤痕切除。我们的计划-称为mCAL,用于“在人工基因座处C as9的多重复合”-可以应用于目前正在使用CRISPR / Cas9方法的任何生物。原则上,它可以用于将合成序列安装到基因组中,生成基因组文库,并对菌株或细胞系进行编程,以便可以在多个基因座上以极高的效率方便地(反复)操作它们。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号